12 November, 2019 Sobi successfully completes acquisition of Dova Pharmaceuticals 31 October, 2019 Sobi publishes report for third quarter 2019 30 September, 2019 Sobi to acquire Dova Pharmaceuticals creating a global growth platform in haematology 29 September, 2019 Sobi strengthens haemophilia position with potential once-weekly haemophilia A treatment 18 June, 2019 New data demonstrates impact of emapalumab in patients with macrophage activation syndrome (MAS) 30 April, 2019 Data Demonstrating the Burden of Severe RSV Disease in Preterm Infants Published in American Journal of Perinatology 8 April, 2019 Sobi Presents Update on State of Newborn Screening for HT-1 in the United States at APHL 2019 Newborn Screening and Genetic Testing Symposium 4 April, 2019 Sobi to Showcase Latest Rare Disease and Specialty Care Research at Multiple Spring 2019 Scientific Meetings 7 February, 2019 Sobi Names Kevin Springman Vice President, Franchise Head in North America 11 January, 2019 First patient randomised in a phase II study evaluating safety and efficacy of anakinra in the treatment of acute gout Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Next page Next › Last page Last »